The pathogenic mechanism of oral bacteria and treatment with inhibitors
- PMID: 34626163
- PMCID: PMC8874083
- DOI: 10.1002/cre2.499
The pathogenic mechanism of oral bacteria and treatment with inhibitors
Abstract
Objectives: The objective of this study was to introduce the evidence obtained through extensive research that periodontitis increases risk of many systemic diseases.
Method: Analysis of some oral bacteria (P. gingivalis, T. denticola, T. forsythia, A. actinomycetemcomitans, and F. nucleatum) and its related treatments and mediators by the specific methods (western blot, ELISA, etc).
Results: This article reviews in detail the evidence obtained through extensive research that periodontitis increases risk of many systemic diseases, including cardiovascular disease, rheumatoid arthritis, and Alzheimer's disease. These diseases are known to be associated with some certain specific gram-negative bacteria as periodontal pathogens, which induce inflammation and related diseases through TLR receptors, kinases, transcriptional factors and other cytokines. We also reviewed the latest research for inhibitors against inflammation and related diseases that have potential to be further applied clinically. In addition, based on a large amount of research evidence, we draw two tables about the mechanism of disease caused by periodontal bacteria, so that readers can easily search and analyze these research results.
Discussion: This review details how the periodontal bacteria and their virulence factors can trigger host immune defense and induce many systemic diseases via inflammation and invasion. This Review also addressed the latest research around inhibitors against inflammation.
Keywords: cell signaling; cytokine(s); inflammation; periodontal medicine.
© 2021 The Authors. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.
Conflict of interest statement
Non‐conflict of interest in the manuscript.
Similar articles
-
A three-year study on periodontal microorganisms of short locking-taper implants and adjacent teeth in patients with history of periodontitis.J Dent. 2020 Apr;95:103299. doi: 10.1016/j.jdent.2020.103299. Epub 2020 Feb 15. J Dent. 2020. PMID: 32070755
-
[Research progress of correlation between periodontal pathogens and systemic diseases].Nan Fang Yi Ke Da Xue Xue Bao. 2020 May 30;40(5):759-764. doi: 10.12122/j.issn.1673-4254.2020.05.24. Nan Fang Yi Ke Da Xue Xue Bao. 2020. PMID: 32897213 Free PMC article. Review. Chinese.
-
Periodontopathogens and human β-defensin-2 expression in gingival crevicular fluid from patients with periodontal disease in Guangxi, China.J Periodontal Res. 2015 Jun;50(3):403-10. doi: 10.1111/jre.12220. Epub 2014 Jul 28. J Periodontal Res. 2015. PMID: 25065393
-
Potential mechanisms between periodontitis and Alzheimer's disease: a scoping review.Can J Dent Hyg. 2023 Feb 1;57(1):52-60. eCollection 2023 Feb. Can J Dent Hyg. 2023. PMID: 36968797 Free PMC article.
-
Occurrence of red complex microorganisms and Aggregatibacter actinomycetemcomitans in patients with diabetes.J Investig Clin Dent. 2015 Feb;6(1):25-31. doi: 10.1111/jicd.12051. Epub 2013 Jul 16. J Investig Clin Dent. 2015. PMID: 23857867
References
-
- Chan, E. C. , Siboo, R. , Keng, T. , Psarra, N. , Hurley, R. , Cheng, S. L. , & Iugovaz, I. (1993). Treponema denticola (ex Brumpt 1925) sp. nov., nom. rev., and identification of new spirochete isolates from periodontal pockets. International Journal of Systematic Bacteriology, 43(2), 196–203. - PubMed
-
- Das, U. N. (2005). COX‐2 inhibitors and metabolism of essential fatty acids. Medical Science Monitor, 11(7), RA233–RA237. - PubMed
-
- Deng, J. , Golub, L. M. , Lee, H. M. , Lin, M. C. , Bhatt, H. D. , Hong, H. L. , Johnson, F. , Scaduto, J. , Zimmerman, T. , & Gu, Y. (2020). Chemically‐modified curcumin 2.24: A novel systemic therapy for natural periodontitis in dogs. Journal of Experimental Pharmacology, 12, 47–60. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources